Trials / Terminated
TerminatedNCT03043794
Study of Stereotactic Radiotherapy for Breast Cancer
A Phase II Study of Preoperative Single Fraction Stereotactic Body Radiotherapy to the Intact Breast in Early Stage Low Risk Breast Cancer: Analysis of Radiation Response
- Status
- Terminated
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 4 (actual)
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · Academic / Other
- Sex
- Female
- Age
- 50 Years – 100 Years
- Healthy volunteers
- Not accepted
Summary
This is a Phase II trial of preoperative stereotactic radiation to the breast for low risk breast cancer.
Detailed description
This is a single arm phase II study design, evaluating the pathologic response (primary endpoint) as well as toxicity, cosmetic outcome, quality of life, and translational correlates (secondary endpoints) to pre-operative stereotactic body radiotherapy (SBRT) to intact breast tumors in patients with hormone-receptor positive early stage breast cancer.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | Stereotactic Body Radiation Therapy SBRT | Stereotactic Body Radiation Therapy to the breast to 21 Gy |
Timeline
- Start date
- 2017-08-01
- Primary completion
- 2021-10-20
- Completion
- 2023-10-22
- First posted
- 2017-02-06
- Last updated
- 2024-09-19
- Results posted
- 2024-09-19
Locations
2 sites across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT03043794. Inclusion in this directory is not an endorsement.